Prognostic Significance of Tumor Growth Rate (TGR) in Patients with Huge Hepatocellular Carcinoma Undergoing Transcatheter Arterial Chemoembolization

Prognostic Significance of Tumor Growth Rate (TGR) in Patients with Huge Hepatocellular Carcinoma Undergoing Transcatheter Arterial Chemoembolization

The prognostic value of the tumor growth rate (TGR) in huge hepatocellular carcinoma (HHCC) patients treated with transcatheter arterial chemoembolization (TACE) as an initial treatment remains unclear. This two-center retrospective study was conducted in 97 patients suffering from HHCC. Demographic...

Full description

Bibliographic Details
Main Authors:	Guobin Chen, Xiaoying Xie, Meixia Wang, Xinkun Guo, Zhenzhen Zhang, Lan Zhang, Boheng Zhang
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Series:	Current Oncology
Subjects:	huge hepatocellular carcinoma tumor growth rate (TGR) transcatheter arterial chemoembolization (TACE) prognosis
Online Access:	https://www.mdpi.com/1718-7729/29/2/38

Similar Items

TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION IN THE TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA ON ADVANCED LIVER CIRRHOSIS
by: A. S. Polekhin, et al.
Published: (2020-03-01)

Recurrence Outcome in Hepatocellular Carcinoma within Milan Criteria Undergoing Microwave Ablation with or without Transarterial Chemoembolization
by: Guobin Chen, et al.
Published: (2022-07-01)

Prognostic factors and an innovative nomogram model for patients with hepatocellular carcinoma treated with postoperative adjuvant transarterial chemoembolization
by: Jing-Xuan Xu, et al.
Published: (2023-12-01)

Effectiveness of postoperative transarterial chemoembolization for huge intrahepatic cholangiocarcinoma
by: SI Anfeng, LEI Zhengqing, YANG Pinghua, JIANG Tao, WANG Xuan, CHENG Zhangjun
Published: (2021-03-01)

Development of a predictive nomogram for postembolization syndrome after transcatheter arterial chemoembolization of hepatocellular carcinoma
by: Jinfeng Bai, et al.
Published: (2024-02-01)

Incorporating Inflammatory Markers and Clinical Indicators into a Predictive Model of Single Small Hepatocellular Carcinoma Recurrence After Primary Locoregional Treatments
by: Qiao W, et al.
Published: (2024-06-01)

Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review
by: Nikolaos Galanakis, et al.
Published: (2018-04-01)

Camrelizumab combined with transcatheter arterial chemoembolization and sorafenib or lenvatinib for unresectable hepatocellular carcinoma: A multicenter, retrospective study
by: Xiumei Jiang, et al.
Published: (2025-03-01)

Analysis and prediction model construction of infection after transcatheter arterial chemoembolization in hepatocellular carcinoma patients
by: DU Jiao, et al.
Published: (2024-12-01)

Correlation between Arterial Enhancement Fraction on CT and Efficacy of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
by: Na GONG, et al.
Published: (2023-01-01)

Transcatheter arterial chemoembolization plus Sorafenib versus transcatheter arterial chemoembolization plus Lenvatinib for intermediate hepatocellular carcinoma
by: Moxuan Wang, et al.
Published: (2024-10-01)

Initial Transarterial Chemoembolization (TACE) Using HepaSpheres 20–40 µm and Subsequent Lipiodol TACE in Patients with Hepatocellular Carcinoma > 5 cm
by: Su Min Cho, et al.
Published: (2021-04-01)

Analysis of the efficacy and influence factors for treatment of primary hepatocellular carcinoma by Huachansu tablets combined with transarterial chemoembolization
by: CHENG Chienshan, ZHANG Tao, WU Junwei, GAO Huifeng, CHEN Jingxian, MENG Zhiqiang
Published: (2024-07-01)

Corrigendum: Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis
by: Jun-Ning Liu, et al.
Published: (2023-06-01)

Evaluation of different scoring systems for repeating Transarterial Chemoembolization in Egyptian patients with Hepatocellular Carcinoma
by: Alhaddad Omkolsoum, et al.
Published: (2024-12-01)

Transcatheter arterial chemoembolization of hepatocellular carcinoma on liver cirrhosis in patients awaiting liver transplantation
by: A. S. Polekhin, et al.
Published: (2021-04-01)

Both anti-angiogenesis and immunotherapy combined with interventional therapy in treatment of hepatocellular carcinoma: effect of hepatic artery infusion chemotherapy compared with hepatic artery chemoembolization
by: ZHANG Xihao, ZHANG Xinyun, CAO Manqing, ZHANG Jinliang, WANG Huaqi, ZHANG Su, FU Zhou, WANG Lu, ZHANG Ti
Published: (2022-05-01)

Role of triphasic computed tomography in prediction of response to transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma patients
by: Ahmed A.E Hassan Desoky, et al.
Published: (2019-01-01)

The role of adjuvant transcatheter arterial chemoembolization following repeated curative resection/ablation for hepatocellular carcinoma with early recurrence: a propensity score matching analysis
by: Kaiquan Huang, et al.
Published: (2024-05-01)

Efficacy of sorafenib plus transcatheter arterial chemoembolization in treating hepatocellular carcinoma with portal vein tumor thrombosis: A meta-analysis
by: Xu Li, et al.
Published: (2024-09-01)

A reasonable identification of the early recurrence time based on microvascular invasion for hepatocellular carcinoma after R0 resection: A multicenter retrospective study
by: Zong‐Han Liu, et al.
Published: (2023-05-01)

Hepatic Arterial Infusion Chemotherapy with Oxaliplatin Plus Raltitrexed as an Alternative Option in Advanced Hepatocellular Carcinoma Patients with Failure of, or Unsuitability for, Transarterial Chemoembolization
by: Yanfang Wu, et al.
Published: (2022-09-01)

Diagnostic value of serum inflammatory markers in predicting early refractoriness of transarterial chemoembolization in patients with Barcelona Clinic Liver Cancer Stage 0, A, and B hepatocellular carcinoma
by: Junhui Yang, et al.
Published: (2024-09-01)

Prognostic Role of Lymphocyte-to-Monocyte Ratio (LMR) in Patients with Intermediate-Stage Hepatocellular Carcinoma (HCC) Undergoing Chemoembolizations (DEM-TACE or cTACE) of the Liver: Exploring the Link between Tumor Microenvironment and Interventional Radiology
by: Roberto Minici, et al.
Published: (2024-06-01)

Identification of Potential Predictors of Prognosis and Sorafenib-Associated Survival Benefits in Patients with Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization
by: Kun He, et al.
Published: (2022-12-01)

Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment
by: Pi-Yi Chang, et al.
Published: (2023-06-01)

Efficacy of Atezolizumab Plus Bevacizumab–Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma
by: Etsuko Moriyama, et al.
Published: (2024-09-01)

Association between transarterial chemoembolization refractoriness and prognosis in Chinese patients with hepatocellular carcinoma: a large retrospective cohort study
by: Qinxue Sun, et al.
Published: (2025-01-01)

Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus: A Systematic Review and Meta-Analysis
by: Jia Deng, et al.
Published: (2023-01-01)

Construction of a prognostic model for hepatocellular carcinoma patients receiving transarterial chemoembolization treatment based on the Tumor Burden Score
by: Jiawei Lin, et al.
Published: (2024-03-01)

Ischemic Stroke Post-Transradial Chemoembolization
by: Almamoon I. Justaniah, et al.
Published: (2024-01-01)

Conventional transarterial chemoembolization followed by irreversible electroporation for hepatocellular carcinoma
by: Meng Zhao, et al.
Published: (2025-02-01)

Cost-effectiveness analysis of transarterial chemoembolization combined with lenvatinib as the first-line treatment for advanced hepatocellular carcinoma
by: Ying He, et al.
Published: (2023-09-01)

Predictors and risk factors of bile duct injury after transcatheter arterial chemoembolization for hepatocellular carcinoma
by: Haohao Lu, et al.
Published: (2024-09-01)

Elevated SLC1A5 associated with poor prognosis and therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma
by: Guixiong Zhang, et al.
Published: (2024-06-01)

Efficacy and Safety of Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Inhibitors for Hepatocellular Carcinoma Patients with Extrahepatic Metastases: A Multicenter Retrospective Study
by: Liu DY, et al.
Published: (2024-11-01)

Transcatheter Arterial Chemoembolization for Hepatic Recurrence after Curative Resection of Pancreatic Adenocarcinoma
Published: (2010-09-01)

Prognostic value of preoperative prealbumin levels in patients with unresectable hepatocellular carcinoma undergoing transcatheter arterial chemoembolisation
by: Kai Lei, et al.
Published: (2023-08-01)

Degradable Magnesium and Its Surface Modification as Tumor Embolic Agent for Transcatheter Arterial Chemoembolization
by: Xinbao Kang, et al.
Published: (2023-01-01)

The value of computed tomography perfusion for assessing the response of hepatocellular carcinoma to transarterial chemoembolization
by: Bui Quang Huynh, et al.
Published: (2024-09-01)